Shaping Global Healthcare by Spearheading the One Health Initiative.
Research & Development
Research and Development is the backbone for product innovation to help improve and extend lives.
Over the years, our R&D team has collaborated with several national and international institutes of repute in the area of vaccines. This has enabled development of top novel products for overall wellbeing.Learn More
Quality management is an integral part of our system.
IIL has robust quality management system which follows finest quality standards across its units.Learn More
Several billion doses
more than 50 countries
1st Indian tissue culture
World’s 1st vaccine
From Managing Director’s Desk
Hyderabad-based vaccine manufacturer Indian Immunologicals Limited (IIL) is all ready to launch vaccines for Hepatitis A (Hep A) and for Measles and Rubella (MR) in 2023.
06 February 2023
Drone delivery of vaccines not only reaches remote terrains faster but also helps in pr
15 November 2022
A veterinary vaccine facility, it will grow Genome Valley’s presence, make jabs for FMD
11 October 2022